Literature DB >> 15486476

Expression of Fc epsilon receptor I on primary sensory neurons in mice.

Tsugunobu Andoh1, Yasushi Kuraishi.   

Abstract

We investigated whether IgE receptors are expressed on sensory neurons in mice. Immunostaining revealed that the high affinity IgE receptor FcepsilonRI was expressed in cultured dorsal root ganglion cells and that FcepsilonRI-immunoreactive cells were mainly positive for the pan-neuronal marker protein gene product 9.5. Many FcepsilonRI-immunoreactive neurons were small or medium in size. IgE was bound to cultured neurons but not glial cells from the ganglia. FcepsilonRI-immunoreactive cells were also positive for the high affinity IgG receptor FcgammaRI. The expression level of FcepsilonRI was lower than that of FcgammaRI. FcepsilonRI-like immunoreactivity was localized on nerve fibers in the skin. The results suggest that IgE acts directly on primary sensory neurons as well as mast cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15486476     DOI: 10.1097/00001756-200409150-00007

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  17 in total

Review 1.  Involvement of Fc receptors in disorders of the central nervous system.

Authors:  Eitan Okun; Mark P Mattson; Thiruma V Arumugam
Journal:  Neuromolecular Med       Date:  2009-10-21       Impact factor: 3.843

2.  Clonal differences in IgE antibodies affect cutaneous anaphylaxis-associated thermal sensitivity in mice.

Authors:  Madison Mack; Elena Tonc; Alyssa Ashbaugh; Abigail Wetzel; Akilah Sykes; Camilla Engblom; Estela Shabani; Carolina Mora-Solano; Anna Trier; Linnea Swanson; Emily Ewan; Tijana Martinov; Devavani Chatterjea
Journal:  Immunol Lett       Date:  2014-08-19       Impact factor: 3.685

3.  How to connect an IgE-driven response with CTL activity?

Authors:  Barbara Platzer; Eleonora Dehlink; Shannon J Turley; Edda Fiebiger
Journal:  Cancer Immunol Immunother       Date:  2011-11-01       Impact factor: 6.968

4.  Harnessing pain heterogeneity and RNA transcriptome to identify blood-based pain biomarkers: a novel correlational study design and bioinformatics approach in a graded chronic constriction injury model.

Authors:  Peter M Grace; Daniel Hurley; Daniel T Barratt; Anna Tsykin; Linda R Watkins; Paul E Rolan; Mark R Hutchinson
Journal:  J Neurochem       Date:  2012-07-09       Impact factor: 5.372

5.  Evidence for neuronal expression of functional Fc (epsilon and gamma) receptors.

Authors:  Hanneke van der Kleij; Nicolas Charles; Khalil Karimi; Yu-Kang Mao; Jane Foster; Luke Janssen; Ping Chang Yang; Wolfgang Kunze; Juan Rivera; John Bienenstock
Journal:  J Allergy Clin Immunol       Date:  2010-02-04       Impact factor: 10.793

Review 6.  Tau-based treatment strategies in neurodegenerative diseases.

Authors:  Anja Schneider; Eckhard Mandelkow
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

7.  Neural pathways in allergic inflammation.

Authors:  L Mirotti; J Castro; F A Costa-Pinto; M Russo
Journal:  J Allergy (Cairo)       Date:  2011-02-09

8.  Allergy influences the inflammatory status of the brain and enhances tau-phosphorylation.

Authors:  Heela Sarlus; Caroline Olgart Höglund; Bianka Karshikoff; Xiuzhe Wang; Mats Lekander; Marianne Schultzberg; Mircea Oprica
Journal:  J Cell Mol Med       Date:  2012-10       Impact factor: 5.310

9.  Comparison of peripheral and central schizophrenia biomarker profiles.

Authors:  Laura W Harris; Sandra Pietsch; Tammy M K Cheng; Emanuel Schwarz; Paul C Guest; Sabine Bahn
Journal:  PLoS One       Date:  2012-10-30       Impact factor: 3.240

10.  IgE actions on CD4+ T cells, mast cells, and macrophages participate in the pathogenesis of experimental abdominal aortic aneurysms.

Authors:  Jing Wang; Jes S Lindholt; Galina K Sukhova; Michael A Shi; Mingcan Xia; Han Chen; Meixiang Xiang; Aina He; Yi Wang; Na Xiong; Peter Libby; Jian-An Wang; Guo-Ping Shi
Journal:  EMBO Mol Med       Date:  2014-07       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.